Pacific Biosciences of California, Inc. (PACB) NASDAQ
1.60
+0.01(+0.63%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
1.60
+0.01(+0.63%)
Currency In USD
| Market Cap | 560.92M |
| Enterprise Value | 1.26B |
| P/E Ratio | -0.88 |
| PEG Ratio | 0.01 |
| Price/Sales Ratio | 3.02 |
| Price/Book Ratio | 90.31 |
| Enterprise/Revenue | 7.37 |
| Enterprise/EBITDA | -7.36 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -3.41 |
| Operating Margin | -3.46 |
| Return On Assets | -0.7 |
| Return On Equity | -11.23 |
| Revenue | 160.01M |
| Revenue/Share | 0.53 |
| Gross Profit | 50.67M |
| EBITDA | -34.2M |
| Net Income | -546.38M |
| Diluted EPS | -1.82 |
| Total Cash | 279.51M |
| Total Cash/Share | 0.93 |
| Total Debt | 759.46M |
| Total Debt/Equity | 141.98 |
| Current Ratio | 6.89 |
| Book Value Per Share | 0.02 |
| 52-Week Change | 44.14 |
| 52-Week High | 2.73 |
| 52-Week Low | 0.85 |
| Moving Average 50 Days | 1.48 |
| Moving Average 200 Days | 1.68 |
| Average Volume | 6.13M |
| Shares Outstanding | 302M |
| % Held by Institutions | 66.73 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |